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Abstract
 
Significant numbers of myocytes die by apoptosis during
myocardial infarction. The molecular mechanism of this
process, however, remains largely unexplored. To facilitate
a molecular genetic analysis, we have developed a model of
ischemia-induced cardiac myocyte apoptosis in the mouse.
Surgical occlusion of the left coronary artery results in apop-
tosis, as indicated by the presence of nucleosome ladders
and in situ DNA strand breaks. Apoptosis occurs mainly in
cardiac myocytes, and is shown for the first time to be lim-
ited to hypoxic regions during acute infarction. Since hy-
poxia-induced apoptosis in other cell types is dependent on
p53, and p53 is induced by hypoxia in cardiac myocytes, we
investigated the necessity of p53 for myocyte apoptosis dur-
ing myocardial infarction. Myocyte apoptosis occurs as
readily, however, in the hearts of mice nullizygous for 
 
p53
 
as in wild-type littermates. These data demonstrate the ex-
istence of a p53-independent pathway that mediates myo-
cyte apoptosis during myocardial infarction. (
 
J. Clin. In-
vest.
 
 1997. 100:1363–1372.) Key words: programmed cell
death 
 
•
 
 ischemic heart disease 
 
•
 
 molecular genetics 
 
•
 
 knock-
out mice 
 
•
 
 nitroimidazoles
 
Introduction
 
Cell death can occur by necrosis or apoptosis (for review see
references 1–3). Necrosis is a passive process for which a dis-
tinguishing characteristic is injury to cellular membranes. The
two most important consequences of this insult are (
 
a
 
) the
breakdown of cellular homeostasis, and (
 
b
 
) the release of in-
tracellular contents, resulting in a marked inflammatory re-
sponse. In contrast, apoptosis is an active, gene-directed pro-
cess in which cells initiate their own deaths in response to
internal or external stimuli. Apoptosis is characterized by con-
densation, margination, and degradation of chromatin, cyto-
skeletal disruption, cell shrinkage, membrane blebbing, and fi-
nally, fragmentation of the cell into membrane-enclosed
apoptotic bodies. The latter are ingested by phagocytic or
neighboring cells, avoiding an inflammatory response. This
mode of death thus serves as an orderly means for multicellu-
lar organisms to eliminate unwanted cells without adversely af-
fecting surrounding tissue. For these reasons, apoptosis is a
key mechanism by which cell turnover is accomplished during
development, homeostasis, and damage surveillance.
Traditionally, cardiac myocyte death during ischemic injury
has been thought to occur exclusively by necrosis. Recently,
however, this view has been challenged by several studies
demonstrating that large numbers of myocytes undergo apop-
tosis in response to both prolonged ischemia and ischemia fol-
lowed by reperfusion in rats, rabbits, and humans (4–9, and re-
viewed in 10). In addition, cultured neonatal cardiac myocytes
undergo apoptosis when deprived of oxygen, glucose, and se-
rum, conditions used as an in vitro surrogate for ischemia (11).
In fact, hypoxia alone is sufficient to induce apoptosis in pri-
mary cultures of neonatal and adult cardiac myocytes (12, 13),
suggesting that decreased availability of oxygen could be a
proximate stimulus for myocyte apoptosis during ischemia.
Myocardial ischemia, however, is a complex state character-
ized by reduced supply of numerous nutrients, inadequate re-
moval of cellular metabolites, and secondary stimuli, such as
mechanical stretch, that result from the effects of ischemia on
myocyte function. With respect to the latter, cardiac myocyte
apoptosis has also been observed in stretched isolated papil-
lary muscles (14) and in models of hemodynamic overload, hy-
pertension, and chronic heart failure (15–18, and reviewed in 10).
One molecular mediator of hypoxia-induced apoptosis is
the tumor suppressor p53. p53 is a transcription factor that ef-
fects cell cycle arrest or apoptosis in response to a variety of
genotoxic and physical stresses (for review see references 3
and 19). Apoptosis may be elicited, in part, by p53-stimulated
transcription of the proapoptotic gene 
 
bax
 
 (20–22), and repres-
sion of the antiapoptotic gene 
 
bcl-2
 
 (20, 23). Protein levels of
p53 increase in response to DNA damage (19), oxidative stress
(24), and significantly, hypoxia (25). p53, in fact, is necessary
for hypoxia-induced apoptosis in mouse embryonic fibroblasts
and experimentally-derived solid tumors (26). Of significance,
p53 is induced by hypoxia in cultured neonatal cardiac myo-
cytes and overexpression of p53 in normoxic myocytes leads to
apoptosis (26a). Accordingly, p53 is likely to play a regulatory
role in ischemia-related myocyte death as well.
The interest in whether acute myocyte loss during myocar-
dial ischemia occurs by apoptosis is motivated by the dual hy-
potheses that apoptosis can be inhibited, and that such inhibi-
tion will result in reduction in infarct size and improved
myocardial function. To address these interrelated issues, how-
ever, it is first necessary to delineate the pathways that medi-
ate apoptosis in cardiac myocytes, and to identify key regula-
tory molecules. To facilitate a molecular genetic approach to
this problem, we have developed and characterized a model of
ischemia-induced myocyte apoptosis in the mouse. We have
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used this model to assess the relationship between hypoxia and
apoptosis in vivo, and to test the necessity of p53 for this pro-
cess during myocardial infarction (MI).
 
1
 
Methods
 
MI model.
 
Myocardial ischemia was induced in the mouse by ligating
the left coronary artery, a method previously used in this species (27).
6–8-week-old C57BL/6J male mice (Jackson Laboratories, Bar Har-
bor, ME) were initially anesthetized with methoxyflurane (Pitman-
Moore, Mundelein, IL) and ventilated through a nose cone with a
tidal volume of 0.2 ml at 120 breaths/min using a rodent respirator
(Model 683; Harvard Apparatus, South Natick, MA). Anesthesia was
maintained subsequently with 0.5% isofluorane (Ohmeda PPD, Lib-
erty Corner, NJ) delivered in 95% O
 
2
 
/5% CO
 
2
 
 through the ventilator.
After thoracotomy in the fourth intercostal space, hearts were exteri-
orized, and the left coronary artery was ligated intramurally 2 mm
from its origin with an 8-0 proline suture. Sham operation involved an
identical procedure, except that the suture was passed through the
myocardium without tying, and was removed. The chest was closed in
two layers, and the animals were allowed to recover. Animals were
reanesthetized with methoxyflurane and killed at various time points
ranging from 30 min to 7 d after coronary ligation. All protocols were
approved by the review board of the Animal Institute of the Albert
Einstein College of Medicine.
 
DNA ladder assay.
 
Hearts were removed and rinsed quickly in
ice-cold PBS. After removal of the atria and great vessels, heart tissue
was frozen in liquid nitrogen, and was stored at 
 
2
 
70
 
8
 
C until further
analysis. Tissue was ground with a mortar and pestle immersed in liq-
uid nitrogen, and was digested in 1 ml lysis buffer (10 mM Tris [pH 8.0],
100 mM NaCl, 25 mM EDTA, 0.5% SDS, 1.0 mg/ml Proteinase K
(Sigma Chemical Co., St. Louis, MO) overnight at 37
 
8
 
C. Protein was
removed by precipitation in NaCl at a final concentration of 1.2 M,
followed by centrifugation at 10,000 
 
g
 
 for 30 min. After extraction of
supernatants with phenol-chloroform, genomic DNA was precipi-
tated with isopropanol, washed in 70% ethanol, resuspended in 10
mM Tris (pH 8.0), 1.0 mM EDTA, and treated with RNase A for 30
min at 37
 
8
 
C. Equal quantities of each sample (30–40 
 
m
 
g) were sub-
jected to electrophoresis on 1.4% agarose gels containing 0.5 
 
m
 
g/ml
ethidium bromide. Molecular weight marker (1 kb) was purchased
from Gibco BRL (Gaithersburg, MD).
 
Terminal deoxynucleotidyltransferase (TdT) nick-end labeling
(TUNEL)/Evans blue costaining.
 
In a separate cohort of animals
that had been subjected to either sham operation or coronary occlu-
sion, the ascending aorta was catheterized through the right carotid
artery and retroperfused with ice-cold 0.9% (wt/vol) saline, followed
by 10% buffered formalin (Sigma Chemical Co.) Approximately 500
 
m
 
l of Evans blue dye (Sigma Chemical Co.) was then injected retro-
grade to delineate the region of myocardial perfusion. The heart was
excised, sliced into three sections perpendicular to its long axis, and
the basal aspect of each section was photographed to record areas
stained by Evans blue dye. The slices were then fixed overnight at 4
 
8
 
C
in 10% buffered formalin, and were embedded in paraffin. TUNEL
was performed on 5-
 
m
 
m sections (TACS 2-TdT Blue Apoptosis De-
tection Kit; Trevigen Inc., Gaithersburg, MD) according to the manu-
facturer’s suggestions, using a 30-min labeling reaction in the pres-
ence of Co
 
2
 
1
 
. Sections were mounted on gridded coverslips (Bellco
Glass, Inc., Vineland, NJ) and visualized by light microscopy (Zeiss
Axiophot; Carl Zeiss, Inc., Thornwood, NY).
For each section, the number of TUNEL-positive myocyte nuclei
in a 0.0625 mm
 
2
 
 area was scored in six anatomically consistent regions
 
(see Fig. 4) using a gridded reticule 
 
3
 
400. Apical, midventricular, and
basal sections were examined for a total of 18 measurements per
heart. Only nuclei that were clearly located in cardiac myocytes were
scored. The number of TUNEL-positive myocyte nuclei per mm
 
2
 
 in
perfused vs. hypoperfused myocardial regions was determined as fol-
lows. Maps of each section were generated using the grids on cover-
slips as a reference. These were compared with the previously ob-
tained photographs of the Evans blue staining, and each of the 18
regions was classified as perfused or hypoperfused. The average num-
ber of TUNEL-positive myocyte nuclei per mm
 
2
 
 in hypoperfused re-
gions was determined by adding the numbers in each hypoperfused
region and dividing by the number of such regions 
 
3
 
 0.0625 mm
 
2
 
.
Similar calculations were made for perfused regions. The number of
TUNEL-positive myocyte nuclei per mm
 
2
 
 averaged over the whole
heart was obtained by summing the numbers of positive nuclei irre-
spective of perfusion status, and dividing by 18 
 
3
 
 0.0625 mm
 
2
 
. The to-
tal number of myocyte nuclei in the same 18 regions was also counted
in serial sections stained with hematoxylin and eosin so that the mean
percentage of total myocyte nuclei could be determined in a similar
manner. Data at each of five time points is reported as the mean
 
6
 
SEM
of three hearts. Results were analyzed using the Kruskal-Wallis statis-
tic with differences considered significant at 
 
P
 
 
 
,
 
 0.05 (28).
 
TUNEL/EF5 costaining.
 
To map hypoxic regions of myocar-
dium, 200 
 
m
 
l of 10 mM 2-(2-nitro-1H-imidazol-1-yl)-
 
N
 
-(2,2,3,3,3-pen-
tafluoropropyl) acetamide (EF5) was administered intravenously 30
min before coronary ligation or sham operation. EF5 forms covalent
adducts with intracellular proteins under conditions of low oxygen
tension (29). Hypoxic cells can then be identified by immunostaining
sections with an antibody against EF5 (30). Hearts were perfused
with ice-cold 0.9% (wt/vol) saline, embedded in OCT (Miles Labora-
tories, Inc., Elkhart, IN), and frozen by immersion in a slurry of etha-
nol/dry ice. Frozen sections (10-
 
m
 
m) were fixed in 4% paraformalde-
hyde for 1 h at 0
 
8
 
C, rinsed extensively, and assayed for TUNEL using
fluorescein-conjugated dUTP (Apoptag Fluorescent DNA Fragmen-
tation Detection kit; Oncor Inc., Gaithersburg, MD) and immediately
photographed. Sections were then blocked and stained with Cy5-con-
jugated ELK3-51, a monoclonal antibody against EF5, as described
(31). For experiments to colocalize hypoxia, apoptosis, and myocytes,
sections were simultaneously stained with a rabbit polyclonal anti-
ventricular myosin light chain 2 (MLC2v) antibody (kind gift of Dr.
Kenneth Chien, University of California, San Diego), followed by
FITC-conjugated goat anti–rabbit secondary antibody (Sigma Chem-
ical Co). Sections were again photographed to document EF5 and/or
MLC2v staining, and then counterstained for total nuclei with Hoechst
33342 (Sigma Chemical Co.) and photographed one final time. Pho-
tography was performed with a Xillix CCD camera (Xillix Technolo-
gies, Vancouver, Canada).
 
p53 (
 
2
 
/
 
2
 
) mice.
 
Mice heterozygous for a disruption in the 
 
p53
 
gene (kind gift of Drs. Tyler Jacks, Massachusetts Institute of Tech-
nology, and Ronald DePinho, Albert Einstein College of Medicine)
(32) were bred to produce homozygous knockout and wild-type prog-
eny. Genotyping was performed on tail DNA using a PCR strategy
with primers X6.5 (5
 
9
 
-ACAGCGTGGTACCTTAT-3
 
9
 
) and X7 (5
 
9
 
-
TATACTCAGAGCCGGCCT-3
 
9
 
) to amplify the endogenous allele,
and primers neo18.5 (5
 
9
 
-TCCTCGTGCTTTACGGTATC-3
 
9
 
) and
X7 to amplify the disrupted allele. Wild-type and 
 
p53
 
 (
 
2
 
/
 
2
 
) mice
were then subjected to left coronary artery occlusion or sham opera-
tion, and were analyzed by DNA ladder assay or TUNEL as de-
scribed above.
 
Results
 
Left coronary artery occlusion induces myocyte apoptosis in the
intact mouse.
 
Currently, the mouse is the mammal whose ge-
nome can be most readily manipulated. Accordingly, we de-
veloped and characterized a model of ischemia-induced car-
diac myocyte apoptosis in this species so that a genetic
 
1. 
 
Abbreviations used in this paper:
 
 EF5, 2-(2-nitro-1H-imidazol-1-yl)-
 
N
 
-(2,2,3,3,3-pentafluoropropyl) acetamide; LV, left ventricular; MI,
myocardial infarction; MLC2v, ventricular myosin light chain 2; TdT,
terminal deoxynucleotidyltransferase; TUNEL, TdT nick-end labeling.
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approach could be used to investigate the mechanism of this
process. Ischemia was produced by ligation of the left coronary
artery resulting in a large myocardial perfusion defect that in-
volved predominantly the left ventricular (LV) free wall (Fig.
1, 
 
D–F
 
). In contrast, perfusion was maintained in sham-oper-
ated animals (
 
A–C
 
). Similar results were observed using Evans
blue dye after 1, 4, 10, 18, and 48 h of ischemia (data not
shown).
To determine whether interruption of coronary blood flow
stimulates apoptosis in the mouse heart and, if so, to delineate
its time course, cardiac DNA was analyzed for nucleosome
ladders, a specific marker of apoptosis, at various times after
left coronary artery occlusion (Fig. 2). Ladders were com-
pletely absent after 1 h of ischemia (lane 
 
8
 
). By 4 h, however,
DNA ladders were faintly evident (lane 
 
9
 
) and were clearly
present after 10 h of ischemia (lane 
 
10
 
). The intensity of the
ladder pattern increased by 18 h (lane 
 
11
 
). This remained the
case up to 48 h after left coronary artery ligation (lane 
 
12
 
). By
72 h, however, the intensity of nucleosome ladders was mark-
edly reduced (lane 
 
12
 
), and was completely absent 7 d after
surgery (lane 
 
14
 
). No nucleosome ladders were observed in
sham-operated hearts at any of these time points (lanes 
 
1–7
 
).
These results were confirmed in a large cohort of mice, which
is summarized in Table I. Thus, left coronary artery occlusion
induces a time-dependent increase in internucleosomal degra-
dation of cardiac DNA, indicative of apoptosis.
Although the formation of DNA nucleosome ladders is a
hallmark of apoptosis, its presence in tissue homogenates pro-
vides no information as to the spatial locations or identities of
Figure 1. Effect of left coronary artery occlusion on myocardial perfusion. Coomassie Blue dye was injected retrograde into the right carotid ar-
tery 30 min after sham operation or ligation of the left coronary artery. Superior aspects of basal (A and D), midventricular (B and E) and apical 
(C and F) sections of sham-operated (A–C) and coronary-occluded (D–F) hearts. Perfused regions are accessible to the dye, and therefore ap-
pear blue.
Figure 2. Time course of internucleosomal fragmentation after coro-
nary occlusion. Genomic DNA was isolated from mouse hearts that 
had been subjected to either sham operation (lanes 1–7) or left coro-
nary artery occlusion (lanes 8–14) and killed 1 h (lanes 1 and 8), 4 h 
(lanes 2 and 9), 10 h (lanes 3 and 10), 18 h (lanes 4 and 11), 48 h (lanes 
5 and 12), 72 h (lanes 6 and 13) and 7 d (lanes 7 and 14) later. DNA 
was resolved on a 1.4% agarose gel and visualized by ethidium bro-
mide staining. 1 kb represents DNA molecular weight marker.
 
Table I. Time Course of Apoptosis During MI. Summary of 
Nucleosome Ladder and TUNEL Assays
 
Nucleosome 
ladder
present*
TUNEL-positive myocyte nuclei
 
‡
 
No./mm
 
2
 
% of total myocyte nuclei
Time point Sham MI Sham MI Sham MI
 
1 h 0/14 0/16 0 0 0 0
4 h 0/10 7/11 0 55.2
 
6
 
22.7 0 3.08
 
6
 
1.08
10 h 0/11 9/10 0 117.3
 
6
 
33.8 0 5.21
 
6
 
1.36
18 h 0/10 16/17 0 158.8
 
6
 
113.6 0 8.66
 
6
 
5.17
48 h 0/9 5/6 0 110.2
 
6
 
61.4
 
§
 
0 11.50
 
6
 
5.93
 
§
 
72 h 0/1 4/4 ND ND ND ND
7 d 0/2 0/4 ND ND ND ND
ND, not determined. *Expressed as the number of hearts containing nu-
cleosome ladders/total number assayed. 
 
‡
 
Expressed as mean
 
6
 
SEM (
 
n
 
 = 3).
For each heart, values represent measurements averaged over the entire
heart. 
 
§
 
Despite the decrease in the number of positive nuclei/mm
 
2
 
 be-
tween 18 and 48 h, the percentage increases slightly, due to a decrease in
the absolute number of remaining myocyte nuclei.
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the particular cell types in which this process is occurring. With
respect to the latter, nonmyocytes in the myocardium, includ-
ing fibroblasts, endothelial cells, and smooth muscle cells, out-
number myocytes by 
 
z
 
 4
 
;
 
1. To address these issues, TUNEL,
an in situ assay of DNA fragmentation, was performed on tis-
sue sections. Fig. 3 shows representative sections from hearts
studied 10 h (
 
A
 
 and 
 
B
 
) and 18 h (
 
C
 
 and 
 
D
 
) after surgery. Con-
sistent with the absence of DNA ladders, no TUNEL-positive
nuclei were observed in the hearts of sham-operated animals
at either time point (
 
A
 
 and 
 
C
 
). In contrast, both myocyte and
nonmyocyte nuclei stained positively for DNA strand breaks
upon pretreatment of the section with DNAse I (
 
F
 
). TUNEL-
positive nuclei were prevalent in the hearts of animals sub-
jected to left coronary artery occlusion (
 
B and D). This staining
did not result from nonspecific binding of reagents to infarcted
tissue, as the signal was absent when TdT was omitted from
the assay (E). Most, although not all, positively stained nuclei
were located within myocytes (B and D and inset). TUNEL-
positive myocyte nuclei were most abundant in apical and mid-
ventricular sections, and were localized primarily to the LV-free
wall. For each heart, the average number of TUNEL-positive
myocyte nuclei was obtained from equally spaced measure-
ments made over the entire heart, including both infarcted and
noninfarcted myocardium. These values are reported in Table
Figure 3. TUNEL staining of heart sections after coronary occlusion. Paraffin-embedded sections of sham-operated (A and C) and infarcted 
hearts (B and D) at 10 (A and B) and 18 h (C and D) were stained for DNA fragmentation by a TUNEL procedure that stains positive nuclei 
blue. The fields depict the LV free wall at the midventricular level. Positive staining in B and D occurs mainly in myocyte nuclei. Inset of D 
shows high power magnification of the fragmented myocyte nucleus indicated by the arrow. Shown in E is a serial section of the section in B, but 
incubated in a reaction lacking TdT. F depicts a serial section of the section shown in A, pretreated with DNAse I to introduce nonspecific strand 
breaks as a positive control. Note that both myocyte (closed arrow) and nonmyocyte nuclei (open arrow) stain positive.
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I as the absolute number of positive myocyte nuclei per mm2,
and the percentage of total myocyte nuclei that were TUNEL-
positive. Statistically significant differences were not observed
between 4 and 48 h, perhaps due to the variability in the extent
of hypoperfusion in our model. Based on the combined DNA
ladder and TUNEL data, we conclude that left coronary artery
occlusion results in cardiac myocyte apoptosis in the mouse.
Myocyte apoptosis during acute MI occurs primarily in hy-
poperfused and hypoxic regions. To further investigate the re-
lationship between hypoperfusion and myocyte apoptosis,
each heart in the preceding experiment had been retroper-
fused with Evans blue dye to delineate regions of hypoperfu-
sion. In this manner, the numbers of TUNEL-positive myocyte
nuclei in different sampling areas of known perfusion status
were determined. Fig. 4 shows representative data from the
hearts of mice subjected to sham operation (A, C, and E) or
left coronary artery occlusion (B, D, and F) 18 h earlier. As
stated previously, no TUNEL-positive nuclei were observed in
the sham-operated heart. The number of TUNEL-positive my-
ocyte nuclei in each of six 0.0625 mm2 fields are indicated for
basal (B), midventricular (D), and apical sections (F) of the in-
farcted heart. Fig. 5 summarizes the data from 15 animals sub-
Figure 4. Spatial relationship between hypoperfusion and myocyte apoptosis. 18 h after sham operation (A, C, and E) or coronary occlusion (B, 
D, and F), Evans blue dye was injected as described in the legend to Fig. 1. Basal (A and B), midventricular (C and D) and apical (E and F) sec-
tions were photographed to document the extent of perfusion, after which sections were processed for TUNEL staining as in Fig. 3. All regions 
of the sham-operated heart are perfused, and lack apoptotic cells. For the infarcted heart, the numbers of positive myocyte nuclei were scored in 
six 0.0625 mm2 fields: four in the LV free wall (a–d), and one each in the septum (e) and right ventricle (f). These quantities are indicated next to 
their respective areas. Note that TUNEL staining falls within hypoperfused regions.
Downloaded from http://www.jci.org on November 15, 2017.   https://doi.org/10.1172/JCI119656
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jected to left coronary artery occlusion for various time inter-
vals. The number of TUNEL-positive myocyte nuclei per mm2
averaged over the perfused regions in each heart was com-
pared to the number averaged over the hypoperfused regions
(n 5 3 hearts at each time point). In regions of the myocar-
dium that were normally perfused, the average number of
TUNEL-positive myocyte nuclei at the 4, 10, 18, and 48 h time
points ranged from 0–8/mm2. In contrast, 200–282 such nuclei/
mm2 were seen on average in hypoperfused regions (P , 0.05
for perfused vs. hypoperfused at each time point). Hypoperfu-
sion did not induce apoptosis uniformly, however, as 10–30%
of hypoperfused regions lacked TUNEL staining. This analysis
demonstrates that TUNEL-positive myocyte nuclei are over-
whelmingly located in hypoperfused myocardium during acute
infarction.
Hypoperfusion deprives the myocardium of many nutri-
ents, including oxygen. A reduction in oxygen tension, or hy-
poxia, is sufficient to induce apoptosis in cultured cardiac myo-
cytes (12, 13). Because of our results showing a strong
correlation between hypoperfusion and apoptosis, we assessed
whether a similar relationship exists between hypoxia and apop-
tosis. To demarcate regions of hypoxia, the 2-nitroimidazole
compound EF5 was injected intravenously before coronary oc-
clusion. EF5 is reduced under hypoxic conditions, facilitating
the formation of covalent linkages with cellular protein thiols
(29, 30). In contrast, under normal cellular oxygen concentra-
tions, this chemical reaction does not occur, and EF5 diffuses
rapidly out of the cell. Since EF5 protein adducts can be identi-
fied by immunostaining with a monoclonal antibody against
the nitroimidazole (29, 30), EF5 provides a marker of hypoxia.
This approach has been used successfully to identify hypoxic
regions in cell culture and in tissue samples (26, 31). As shown
in Figs. 6 B and 7 A, left coronary artery occlusion resulted in
EF5 staining in the LV free wall, indicating hypoxia. Since
these regions coincided with regions that stained positively for
the myocyte marker MLC2v (Fig. 7 C), we conclude that car-
diac myocytes were included among the hypoxic cells. This in-
dicates that coronary artery occlusion results in decreased oxy-
gen levels in cardiac myocytes. As expected, the most intense
EF5 staining was observed in the subendocardium (Fig. 6 B).
The cells abutting the LV cavity, which include endocardial
cells that are not stained by the myocyte marker (compare C
and D, Fig. 7), as well as the first few layers of myocytes, were
spared from hypoxia, possibly due to direct diffusion of oxygen
from the ventricular chamber. Conversely, EF5 staining was
absent in a heart subjected to sham operation (Fig. 6 A).
TUNEL staining of this section was completely negative (data
not shown). In infarcted hearts, multiple TUNEL-positive nu-
clei were evident in EF5-positive regions (Figs. 6 D and 7 B).
In contrast, TUNEL-positive nuclei were absent from EF5-
negative regions of these same hearts (Fig. 6 C and 7 B). Thus,
apoptosis occurred exclusively in hypoxic myocardium. The
converse was not true, however; some hypoxic regions lacked
apoptotic myocytes (Figs. 6 D and 7 B). Taking the Evans blue
and EF5 data together, we conclude that cardiac myocyte apop-
tosis after coronary occlusion correlates strongly with both hy-
poperfusion and hypoxia.
p53 is not required for myocyte apoptosis during acute MI.
The strong correlation between hypoxia and apoptosis after
coronary occlusion suggested that oxygen deficiency plays a
stimulatory role, as has been demonstrated in vitro (12, 13).
Furthermore, since p53 is both necessary for hypoxia-induced
apoptosis (26) and is sufficient to induce cardiac myocyte apop-
tosis (26a), we assessed the requirement of p53 for ischemia-
induced apoptosis using mice in which the p53 gene had been
inactivated by insertional mutagenesis (32). Unexpectedly, nu-
cleosome ladders of similar intensities were evident in both
p53 (2/2) and wild-type littermates subjected to left coronary
artery occlusion (Fig. 8). This was true at both early (10 h) and
late (48 h) time points for a total of eight knockout mice, indi-
cating that the absence of p53 neither blocked nor delayed my-
ocyte apoptosis. Since it was formally possible that different
populations of cells were undergoing apoptosis in the presence
and absence of p53, TUNEL staining of heart sections from
both genotypes was performed. No differences in the distribu-
tion of TUNEL-positive nuclei were observed, however (data
not shown). Thus, abrogation of p53 does not affect the occur-
rence or kinetics of cardiac myocyte apoptosis during MI, im-
plying that apoptosis in this model occurs via a p53-indepen-
dent pathway.
Discussion
This study demonstrates that cardiac myocytes undergo apop-
tosis after coronary occlusion in the mouse. Strong evidence in
support of this conclusion is provided by the data from the nu-
cleosome ladder assays, which are specific for apoptosis and
the TUNEL assays, which, while not specific for internucleoso-
mal fragmentation, permit identification of the cells that are
involved. Apoptotic markers are observed as early as 4 h after
coronary artery ligation, and persist for as long as 48 h. A simi-
lar time course was observed in a previous study of cardiac cell
death during MI in the rat (7). The persistence of internucleo-
somal fragmentation suggests that new apoptotic events, in-
Figure 5. Quantity of TUNEL-positive myocyte nuclei per unit area 
in perfused and hypoperfused myocardium. At each time point indi-
cated, infarcted hearts were subjected to in situ analysis as described 
in the legend to Fig. 4. Six fields each in apical, midventricular, and 
basal cross-sections were scored for each heart. Each field was desig-
nated as perfused or hypoperfused based on accessibility to Evans 
blue dye. The average number of TUNEL-positive myocyte nuclei/
mm2 in perfused (closed bars) or hypoperfused (open bars) fields was 
calculated for each heart. Data is reported as the mean6SEM of 
three hearts at each time point. *Indicates P , 0.05.
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volving additional myocytes, occur throughout the 48-h period.
The basis for this interpretation is the rapidity (minutes to
hours) with which apoptosis is executed in some other systems,
such as Caenorhabditis elegans (1, 33). The kinetics of apopto-
sis, however, may not be uniform in all cell types and situations
(33). For example, in sympathetic neurons deprived of nerve
growth factor, more than 12 h pass from when the first mor-
phological signs of apoptosis are observed until the final stages
of cell contraction and membrane blebbing (34). In addition,
clearance of apoptotic debris by phagocytosis could be rate-
limiting in the heart, resulting in persistence of apoptotic
markers. For these reasons, it is possible that one population
of myocytes is being detected at multiple time points, a hy-
pothesis that cannot be excluded using currently available apop-
tosis detection assays. Even the observed temporal increase in
the intensity of nucleosomal ladders does not constitute proof
of new apoptotic events, as this could reflect further fragmen-
tation of DNA within the same population of cells.
Although there is no doubt that significant necrosis occurs
during MI, our estimate that 3–12% of myocyte nuclei in the
entire heart are TUNEL-positive at any given time point sug-
gests that a sizable proportion of myocytes undergo apoptosis.
Without knowing the duration of TUNEL positivity after a
single apoptotic event, however, we are unable to calculate the
cumulative number of apoptotic myocytes over the course of
acute infarction. Even so, the minimum rate of myocyte apop-
tosis as predicted from the above estimate argues that apop-
totic cell death is an important contributor to myocyte loss
during MI. The potential clinical significance of this observa-
tion is that apoptosis, in contrast to necrosis, is an active pro-
cess that could, in principle, be inhibited. Inhibition of myo-
cyte apoptosis during MI could translate into reduction in
infarct size and improvement in cardiac function. While an at-
tractive possibility, however, this outcome is not assured. Pre-
vention of myocyte apoptosis is unlikely to be beneficial if the
same cells undergo necrosis a short time later. In addition,
even if subsequent necrosis were not a concern, myocytes res-
cued from apoptosis may not remain functional. Furthermore,
removal of damaged myocytes through apoptosis may be a
mechanism by which the heart limits the extent of the poten-
tially more destructive process of necrosis with its accompany-
ing inflammation; consequently, inhibition of apoptosis may
actually have deleterious effects on cardiac function. Clearly,
these questions need to be addressed to evaluate the potential
clinical benefit of inhibiting myocyte apoptosis during MI.
The most direct and definitive approach to resolving these
Figure 6. Spatial relationship between hypoxia and apoptosis. Animals were injected with hypoxia marker EF5 30 min before sham operation 
(A) or left coronary occlusion (B–D). Frozen sections of hearts from mice killed 10 h after surgery were sequentially stained for TUNEL (C and 
D) and EF5 (A and B, 3 3 2.5 mm2 field). C and D are high magnification (0.4 3 0.25 mm2 field) views of TUNEL staining of the boxed regions 
labeled c and d, respectively, in B. TUNEL-positive nuclei are found exclusively within regions of EF5 binding.
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issues is to inhibit myocyte apoptosis. To accomplish this, an
understanding of the molecular pathways that mediate cardiac
myocyte apoptosis is required. The major objectives of the cur-
rent study were to develop and characterize a mouse model,
and to use it to delineate genetic components of ischemia-
induced apoptosis. The spatial correlation between hypoperfu-
sion and apoptosis that has been observed here and in a previ-
ous study (8) suggests that the death stimulus involves the ab-
sence of a substance that would normally be supplied by the
circulation. The most obvious nutrient in short supply is oxy-
gen, lack of which may directly lead to cell death by inhibiting
oxygen-dependent metabolic processes, as has been demon-
strated in vitro in cardiac myocytes (12, 13). This hypothesis is
supported by the fact that apoptosis during MI was observed
only in EF5-positive, hypoxic regions of the myocardium. Not
all hypoxic areas were apoptotic, however, and even within
those regions that did contain TUNEL-positive nuclei, not all
cells were involved. This heterogeneity may be due to subtle
differences in the degree of hypoxia within different EF5-posi-
tive regions. In fact, the intensity of EF5 staining varied to a
certain extent among infarcts, and even within an infarct.
Although the majority of hypoxia-induced apoptosis in tu-
mor cells was inhibited upon disruption of p53 (26), ischemia-
induced myocyte apoptosis continues undiminished in its ab-
sence. We were not able to evaluate whether there were subtle
changes in the quantity of apoptotic cells in the absence of p53,
due to inherent variability in the size of perfusion defects in
our model. Nevertheless, the degree of apoptosis observed in
the p53 knockout mice demonstrates that a major portion of
this process must occur via a p53-independent pathway. This is
in stark contrast to the low levels of p53-independent apopto-
sis that were observed in hypoxic tumors (26). This discrep-
ancy may be due to differences in cell type. Alternatively,
there may be other p53-independent stimuli that operate in
conjunction with hypoxia to elicit myocyte apoptosis after cor-
onary occlusion. These could include deprivation of cardiac
survival factors (35) or the secondary consequences of myocar-
dial hypoperfusion, such as increased mechanical load (9, 14,
15, 17). In combination with various knockout and transgenic
mice, the model described in this report will be useful in identi-
fying alternative stimuli and pathways that mediate myocyte
apoptosis. Our results indicate clearly that at least one of these
stimuli, whether it be hypoxia or some other factor, activates a
p53-independent pathway that leads to the apoptotic cell death
of cardiac myocytes.
In conclusion, we describe a mouse model of MI in which
Figure 7. Hypoxia and apoptosis colocalize to cardiac myocytes. After injection of EF5, coronary occlusion was performed, and mice were killed 
10 h later. Frozen sections were sequentially stained and photographed for TUNEL, EF5, and MLC2v, and finally, total nuclei with Hoechst 
33342. Shown is the same 0.95 3 0.70 mm2 field exhibiting EF5 staining (A, Cy5), TUNEL (B, FITC under high gain), MLC2v (C, FITC), and to-
tal nuclei (D). TUNEL staining and hypoxia occur within cardiac myocytes. Endocardial cells (indicated with arrow in D) and myocytes abutting 
the LV cavity are neither hypoxic nor apoptotic. Note that B was photographed before immunostaining for MLC2v.
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cardiac myocyte apoptosis is observed exclusively in hypoxic
myocardium over 48 h. This model enables us to delineate the
molecular components that regulate this complex process. We
have shown, in fact, that myocyte apoptosis following coronary
occlusion occurs independently of p53, suggesting that multi-
ple pathways combine to activate apoptosis in the ischemic
heart.
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